2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
2
Congenital Abnormalities
2
Brain Neoplasms
2
Wilms Tumor
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neutropenia
1
Neurotoxicity Syndromes
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Interventions
Cyclophosphamide
78
fludarabine phosphate
77
Azacitidine
76
Peripheral Blood Stem Cell Transplantation
63
Busulfan
53
Mycophenolic Acid
51
Whole-Body Irradiation
50
Tacrolimus
48
Cytarabine
43
Cyclosporine
43
Methotrexate
37
Decitabine
36
Filgrastim
32
Antilymphocyte Serum
30
venetoclax
27
Radiotherapy
25
Melphalan
23
fludarabine
22
Etoposide
18
Methylprednisolone
17
Biopsy
15
Cyclosporins
14
Specimen Handling
13
Injections
13
Granulocyte Colony-Stimulating Factor
13
Flow Cytometry
13
Cord Blood Stem Cell Transplantation
13
decitabine and cedazuridine drug combination
12
Idarubicin
12
Stem Cell Transplantation
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
Lithium Carbonate
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts